carcinoma
Showing 76 - 100 of 189
Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial in Worldwide (Sym004, Futuximab, Modotuximab)
Terminated
- Metastatic Colorectal Cancer
- +2 more
- Sym004
- +2 more
-
Duarte, California
- +17 more
Sep 7, 2020
Carcinoma, Advanced Cancer Trial in Grand Rapids, San Antonio (TRX-818 capsules)
Completed
- Carcinoma
- Advanced Cancer
- TRX-818 capsules
-
Grand Rapids, Michigan
- +1 more
May 19, 2020
Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Israel, United States
Withdrawn
- Carcinoma
- +2 more
- UGN-101 instillations
-
Los Angeles, California
- +4 more
May 5, 2020
Assessment of Patient Experience During Treatment for Cancer
Completed
- Carcinoma
-
Palo Alto, CaliforniaStanford University, School of Medicine
Apr 27, 2020
Carcinoma, Sarcoma, Myeloma Trial in New York (radiation, procedure, other)
Completed
- Carcinoma
- +4 more
- [18F]-SKI-249380
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 24, 2020
Carcinoma, Non-small-cell Lung Cancer, Lung Tumors Trial in Beijing
Completed
- Carcinoma
- +2 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Mar 26, 2020
Carcinoma, NSCLC Trial in Columbia (Karenitecin (BNP1350))
Completed
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Karenitecin (BNP1350)
-
Columbia, MissouriEllis Fischel Cancer Center
Mar 10, 2020
What Benefit ofFull Analysis of Exome? Routine Care Study in
Completed
- Carcinoma
-
Dijon, FranceCGFL
Nov 19, 2019
Carcinoma, NSCLC Trial (sintilimab plus anlotinib, Chemotherapy)
Unknown status
- Carcinoma
- Non-small Cell Lung Cancer
- sintilimab plus anlotinib
- Chemotherapy
- (no location specified)
Oct 10, 2019
Carcinoma, Neuroendocrine Tumors Trial in United States (Cixutumumab, depot octreotide)
Completed
- Carcinoma
- Neuroendocrine Tumors
- Cixutumumab
- depot octreotide
-
Los Angeles, California
- +9 more
Sep 6, 2019
Peritoneal Carcinomatosis, Colorectal Cancer, Carcinoma Trial in Nijmegen (drug, radiation, procedure)
Unknown status
- Peritoneal Carcinomatosis
- +4 more
- Indium-111-DOTA-Labetuzumab-IRDye800CW injection
- +2 more
-
Nijmegen, NetherlandsRadboudumc
Sep 12, 2019
Identifying Genomic Mutations of Multiple Primary Lung Cancers
Unknown status
- Carcinoma
- +2 more
- (no location specified)
Aug 26, 2019
Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell
Completed
- Carcinoma
- +4 more
- Biological sample
-
Bordeaux, FranceUniversity Bordeaux Hospital
Aug 2, 2019
Mixed Tumor, Malignant, Biopsy, Resection Trial (Optical Coherence Tomography (OCT) with Vivosight, Optical Coherence Tomography
Withdrawn
- Mixed Tumor, Malignant
- +4 more
- Optical Coherence Tomography (OCT) with Vivosight
- Optical Coherence Tomography (OCT) with Skintell
- (no location specified)
Apr 2, 2019
Carcinoma, Advanced Cancer Trial in Tainan City (TRX-818 capsules)
Completed
- Carcinoma
- Advanced Cancer
- TRX-818 capsules
-
Tainan City, Tainan, TaiwanNational Cheng Kung University Hospital
Mar 27, 2019
Cancer, Carcinoma, Solid Tumors Trial in Baltimore, Charleston, Charlottesville (Ceramide NanoLiposome)
Unknown status
- Cancer
- +3 more
- Ceramide NanoLiposome
-
Baltimore, Maryland
- +2 more
Feb 26, 2019
Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine Trial in Worldwide (Everolimus)
Completed
- Advanced and Metastatic Silent Neuro-Endocrine Tumors
- +6 more
-
Bordeaux, France
- +39 more
Aug 14, 2018
Small Pulmonary Nodules by Multi-omics Sequencing
Completed
- Carcinoma
- +2 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jan 8, 2019
Carcinoma, Lung Tumor, Small Cell Lung Cancer Trial in Shijiazhuang (Anlotinib Hydrochloride)
Unknown status
- Carcinoma
- +2 more
- Anlotinib Hydrochloride
-
Shijiazhuang, Hebei, ChinaThe First Hospital of Shijiazhuang
Dec 19, 2018
Carcinoma, NSCLC, Lung Tumor Trial in Shijiazhuang (Sintilimab, Anlotinib Hydrochloride)
Unknown status
- Carcinoma
- +2 more
- Sintilimab
- Anlotinib Hydrochloride
-
Shijiazhuang, Hebei, ChinaThe First Hospital of Shijiazhuang
Dec 5, 2018
NSCLC, Carcinoma, NSCLC Trial in New York (Ensartinib, Durvalumab)
Completed
- Non-small Cell Lung Cancer
- +2 more
-
New York, New YorkResearch Facility
Oct 25, 2018
Stage III-IV Lung Cancer Patients
Unknown status
- Carcinoma
- +2 more
-
Beijing, Beijing, China
- +7 more
Nov 9, 2018
Prostatic Diseases, Genital Tumors, Male, Urogenital Tumors Trial in Los Angeles (Ixabepilone)
Terminated
- Prostatic Diseases
- +7 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Oct 22, 2018